END-DIALYSIS OVERWEIGHT AND CHRONIC INFLAMMATION. A DANGEROUS CONNECTION by Movilli, Ezio et al.
SP706 IS REPORTED FISH INTAKE REFLECTED IN THE PLASMA
PHOSPHOLIPID CONTENT OF MARINE N-3
POLYUNSATURATED FATTY ACIDS IN PATIENTS WITH END
STAGE RENAL DISEASE?
Jesper Rantanen1,3, Erik Schmidt2,1, Sam Riahi2,1, Jeppe Christensen1,3
1Department of Clinical Medicine Aalborg University Aalborg Denmark, 2AF study
Group, Department of Cardiology Aalborg University Hospital Aalborg Denmark and
3Department of Nephrology Aalborg University Hospital Aalborg Denmark
INTRODUCTION AND AIMS: Patients with end stage renal disease (ESRD) have a
very high premature mortality. Most deaths are caused by cardiovascular
complications and almost 30% are due to sudden cardiac death (SCD). A high intake of
long chain n-3 polyunsaturated fatty acids (PUFA) from fatty ﬁsh and ﬁsh oil is
associated with a reduced risk of SCD and cardiovascular complications in the general
population and in patients with ESRD. Nevertheless, previous studies have reported
that patients with ESRD have a low intake of ﬁsh and a low content of marine n-3
PUFA in plasma and platelets. We aimed to examine to what extent reported ﬁsh
intake was reﬂected in the content of n-3 PUFA in plasma phospholipids in patients
with ESRD.
METHODS: In a cross-sectional study, 169 unselected patients receiving chronic dialy-
sis in the North Denmark Region were included. Intake of ﬁsh (without distinction
between lean or fatty ﬁsh) was assessed by questionnaires calculating a ﬁsh score with a
range from 2 (never eating ﬁsh) to 12 (eating ﬁsh at least twice daily). The content of
marine n-3 PUFA (eicosapentaenoic acid, docosahexaenoic acid and docosapentaenoic
acid) was measured in plasma phospholipids by gas chromatography with results given
as weight percentage.
RESULTS: The mean age was 62.3 (614.1) years, 65% were men and the median
dialysis vintage was 1.8 [0.6; 5.7] years. Reported ﬁsh intake was positively associated
with the level of total n-3 PUFAs in plasma phospholipids (r=0.37, p<0.0001 - ﬁgure
below text). A total of 22 patients reported a supplemental intake of ﬁsh oil capsules.
Exclusion of these patients from the analysis did not change the results.
CONCLUSIONS: In patients with ESRD, reported ﬁsh intake was positively associated
with the content of n-3 PUFA in plasma phospholipids. The correlation was only
moderate, which might be explained by lack of distinction between lean or fatty ﬁsh in
the questionnaire. The result indicates that reported ﬁsh intake in patients with ESRD
only to some extent is able to predict the content of n-3 PUFA in plasma.
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INTRODUCTION AND AIMS: Attaining dry body weight is paramount in dialysis
practice, but this goal is not always reached. We hypothesized that the amount of end-
dialysis overweight (edOW), could be associated to increased chronic inﬂammation
and mortality. Aim of the study: to evaluate the effect of edOW on serum C-reattive
protein(hsCRP) concentrations and on survival in a cohort of 182 prevalent HD
patients (pts) followed for 36 months.
METHODS: In 182 pts (117 men, age 65612 years, vintage 48 months; range 6-336),
edOW was present in 98/182 (54%) pts. Mean value was 0.460.2 Kg (range: 0.1-1.4).
In the 98 pts with edOW (Group 1) and in the other 84 (Group 2) we evaluated:
Ultraﬁltration rate(UFR), hsCRPdry body weight (dBW), Kt/V, protein catabolic rate
(PCRn), interdialytic weight gain (IDWG), mean arterial pressure (MAP). Unpaired
Student’s t test was employed to compare groups, linear regression analysis to test
correlations, log-rank test and Kaplan-Meier curves to evaluate survival.
RESULTS:Mean UFR was 11.762.8 ml/Kg/hour, dBW 64612 Kg, hsCRP 6.6 (0.2-36)
mg/L, Kt/V 1.2760.09, PCRn 1.0660.10 g/Kg/day, IDWG 2.860.4 Kg, MAP 9766.5
mmHg. edOW and hsCRP were directly and signiﬁcantly correlated (r= 0.67;
p<0.0001). Comparison between pts with (Group 1) and without (Group 2) edOW
showed signiﬁcant differences in: UFR (12.762.6 vs 10.962.6 ml/Kg/hour; p< 0.0001),
hsCRP (13.068.1 vs 5.265.3 mg/L; p< 0.0001), and PCRn (1.0360.09 vs 1.0860.10 g/
Kg/day; p<0.004). 98 pts (54%) died during follow-up for cardiovascular complications
in 69% of cases. Survival curves showed signiﬁcantly greater mortality in Group 1 vs
Group 2 in relation to the amount of edOW, and hsCRP (p<0.0001).
CONCLUSIONS: : edOW and chronic inﬂammation are directly correlated in HD pts,
and both are associated to a greater long-term risk of mortality.
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INTRODUCTION AND AIMS: Despite the continuous improvement of dialysis
technology and pharmacological treatment, mortality rates for dialysis patients are still
high. Hemodialysis patients have a substantial cardiovascular disease burden.
Monocyte heterogeneity is widely acknowledged and substantial evidence suggests that
pro-inﬂammatory (CD16 positive) monocytes may contribute to the development of
atherosclerosis.
METHODS:Monocyte subsets were measured by ﬂow cytometry.
RESULTS:We prospectively studied the predictive value of CD16 postive monocyte
subtypes for total and cardiovascular death in 136 HD patients during a 5.6 years of
follow-up. CD16 positive monocytes were independently associated with both mortal-
ity after adjustment for variables in patients with pre-existing cardiovascular disease
(CVD). Kaplan-Meier analysis revealed that CD16 positive monocytes counts in the
highest quartile had a signiﬁcantly higher all-cause mortality rate compared to the rest
of the quartiles. However, in our analysis stratiﬁed by percentage of CD16, besides
those in the highest quartile, patients in the lowest quartile also had an elevated
adjusted hazard ratio for cardiovascular death (HR=6.26, p=0.01).
CONCLUSIONS:We found that CD16 positive monocytes were independently
associated with both cardiovascular and all-cause mortality in HD patients with pre-
existing CVD. Nevertheless, a subset of patients with monocyte counts close to the nor-
mal range also portends a poor prognosis
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INTRODUCTION AND AIMS: Three distinct ghrelin gene products, namely,
acylghrelin, desacylghrelin, and obestatin have been identiﬁed. Acylghrelin is a potent
stimulator of food intake and gastrointestinal motility while desacyl ghrelin exerts
opposite effects on food intake and gastrointestinal motility. The effects of obestatin on
food intake and gastrointestinal motility have been controversial. Fatty acid-binding
protein 4 (FABP4) mainly expressed in adipocytes and macrophages is associated with
obesity, insulin resistance, and atherosclerosis. A positive relationship between serum
ghrelin and NT-proBNP levels in patients with pulmonary hypertension was reported.
The present study investigated the relationships among acylghrelin, deacylghrelin lev-
els, obestatin, FABP4 and the N-terminal prohormone of B-type natriuretic peptide
(NT-proBNP) in hemodialysis dialysis (HD) patients.
METHODS: The study included 60 hemodialysis (30 male, 30 female) and 20 (9 male,
11 female) age, gender and body mass index (BMI) matched healthy control subjects.
Serum ghrelin, obestatin and FABP4 levels were measured by enzyme immunoassay
(ELI-SA, Enzyme Linked Immunosorbent Assay). NT-proBNP levels were determined
using chemiluminescent immunometric assay.
RESULTS: The study included 60 hemodialysis and 20 age, gender and body mass
index (BMI) matched healthy control subjects. Serum desacylghrelin, FAB4 and NT-
proBNP levels were higher in HD patients [(1080,96602,8 vs 499,96313,6 pg/mL),
(11,762,7 vs 1,960,8 ng/mL), (12946,2615279,6 vs189,36195,6 pg/mL) respectively]
than those of controls (p:0.000). There was no difference according to serum acylghre-
lin, and obestatin levels between HD patients and controls. Serum acylghrelin levels
were positively correlated with serum albumin levels (r:0.282, p:0.029), wherease serum
acylghrelin levels were negatively correlated with serum desacylghrelin levels (r:-0.358,
p:0.005). Serum acylghrelin levels were not correlated with age, dialysis duration, serum
creatinine, albumin, calcium, phosphate, obestatin, FAB4, NT-proBNP and intact para-
throid hormone (iPTH) levels (p>0.05). Serum deacylghrelin levels were negatively
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